Literature DB >> 22883322

Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases.

Filippo Graziani1, Paolo Vescovi, Giuseppina Campisi, Gianfranco Favia, Mario Gabriele, Giovanni Maria Gaeta, Stefano Gennai, Franco Goia, Mario Miccoli, Franco Peluso, Matteo Scoletta, Luigi Solazzo, Giuseppe Colella.   

Abstract

PURPOSE: The aim of this study was to evaluate the results of the surgical treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a large cohort.
MATERIALS AND METHODS: A retrospective cohort multicenter study was designed. Patients were enrolled if they were diagnosed with BRONJ and received operative treatment. Data on demographic, health status, perioperative, and surgical factors were collected retrospectively. The primary outcome variable was a change in BRONJ staging (improvement, worsening, or no change). Interventions were grouped by local debridement and resective surgery. Data were collected for other variables as cofactors. Univariate analysis and logistic regressions were then performed.
RESULTS: Of the 347 BRONJ-affected subjects, 59% showed improvement, 30% showed no change, and 11% showed worsening. Improvement was observed in 49% of cases treated with local debridement and 68% of cases treated with resective surgery. Multivariate analysis indicated that maxillary location, resective surgery, and no additional corticosteroid treatment were associated with a positive outcome.
CONCLUSIONS: Surgical treatment of BRONJ appeared to be more effective when resective procedures were performed. Nonetheless, other factors, such as the absence of symptoms and the types of drug administration, should be taken into account before clinical decisions are made.
Copyright © 2012 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22883322     DOI: 10.1016/j.joms.2012.05.019

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  25 in total

1.  Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw.

Authors:  Yoon Ho Kim; Ho Kyung Lee; Seung Il Song; Jeong Keun Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-10-24

2.  Conservative surgical treatment in the management of BRONJ: a case series of 129 consecutive cases.

Authors:  M Gabriele; F La Ferla; S Cei; M Nisi; F Graziani
Journal:  Ann Stomatol (Roma)       Date:  2013-10-24

Review 3.  Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Victoria Rollason; Alexandra Laverrière; Laura C I MacDonald; Tanya Walsh; Martin R Tramèr; Nicole B Vogt-Ferrier
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

4.  Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.

Authors:  D Yoshiga; M Sasaguri; K Matsuo; S Kokuryou; M Habu; M Oda; M Kodama; H Tsurushima; O Sakaguchi; T Sakurai; J Tanaka; Y Morimoto; I Yoshioka; K Tominaga
Journal:  Osteoporos Int       Date:  2015-06-03       Impact factor: 4.507

5.  Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.

Authors:  Takuma Watanabe; Takeshi Yoshida; Sachi Akizuki; Shigeki Yamanaka; Kazumasa Nakao; Shizuko Fukuhara; Keita Asai; Ryuji Uozumi; Kazuhisa Bessho
Journal:  J Bone Miner Metab       Date:  2022-05-09       Impact factor: 2.626

6.  Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.

Authors:  Mitsunobu Otsuru; Saki Hayashida; Kota Morishita; Maho Murata; Sakiko Soutome; Miho Sasaki; Yukinori Takagi; Misa Sumi; Masahiro Umeda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

Review 7.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

8.  Nonsurgical Management of Medication-Related Osteonecrosis of the Jaws Using Local Wound Care.

Authors:  Danny Hadaya; Akrivoula Soundia; Earl Freymiller; Tristan Grogan; David Elashoff; Sotirios Tetradis; Tara L Aghaloo
Journal:  J Oral Maxillofac Surg       Date:  2018-05-29       Impact factor: 1.895

9.  Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy.

Authors:  Giacomo Oteri; Gianluca Trifirò; Matteo Peditto; Loredana Lo Presti; Ilaria Marcianò; Francesco Giorgianni; Janet Sultana; Antonia Marcianò
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

10.  The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw.

Authors:  Sotirios Tetradis; Christos Perisanidis; Nikolaos G Nikitakis; Polytimi Paschalidi; Ioannis Gkouveris; Akrivoula Soundia; Evangelos Kalfarentzos; Emmanouil Vardas; Maria Georgaki; Georgios Kostakis; Boban M Erovic
Journal:  Clin Oral Investig       Date:  2020-09-22       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.